Immunosuppressant Drug Monitoring Market: By Product (Equipment, Consumables) By Technology (Proteomics Technologies, Immunoassays, Electrophoresis, Spectrometry) By Drugs (Antibodies, Corticosteroids, Calcineurin Inhibitors, Anti-Proliferative Agents, mTOR Inhibitors, Others) By Disease (Autoimmune Disorders, Organ Transplantation, Non-Auto Immune Inflammatory Diseases) By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Academic Institutes) By Geography (Latin America, North America, Asia Pacific, The Middle East and Africa and Europe)

 

Immunosuppressant drug monitoring is most vital for monitoring of immunosuppressant drug levels in patients in order to prevent the organ rejection. It is one of the applications of therapeutic drug monitoring, aims to maintain the adequate concentration of drugs in body fluids in order to refine patient care by adjusting individual drug dosage for the better outcomes. Immunosuppressant drugs are known as anti-rejection drugs, which inhibits the activity of immune system that are most commonly used in organ transplantations, auto immune disorders like multiple sclerosis, rheumatoid arthritis and chron’s disease.  Growing demand for organ transplantations, advancements in procedures of organ transplantation, growing prevalence of auto immune diseases are expected to witness tremendous growth of the immunosuppressant drug monitoring market. Furthermore, favorable reimbursement policies, growing awareness among the people regarding healthcare and organ transplantations are expected to fuel immunosuppressant drug monitoring market. However, strict regulatory frameworks, availability of alternative therapies like stem cell therapy for immunosuppression are expected to hamper the growth of immunosuppressant drug monitoring market. Therapeutic drug monitoring is a method of determining the drug's safe and effective dosage. Therapeutic Drug Monitoring is a technique for treating and monitoring drug concentrations in body fluids, most often plasma. A major element driving the global market's growth is the growing demand for better healthcare facilities in developing countries to meet the needs of a growing urban population. Furthermore, the growing elderly population and the development of novel medication management systems, particularly in emerging nations, are two major drivers driving market expansion.